NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

11 hedge funds and large institutions have $209K invested in Northwest Biotherapeutics, Inc. Common stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MSAM
1
Moloney Securities Asset Management
Missouri
$148K

Top Sellers

1
MWM
1
Maripau Wealth Management
Indiana
$0
2
SL
2
Sentinus LLC
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MSAM
1
Moloney Securities Asset Management
Missouri
$148K 462,215 +37,905 +9%
OCG
2
Opus Capital Group
Ohio
$19K 60,150 – –
WJWM
3
Williams Jones Wealth Management
New York
$11.2K 35,000 – –
EFG
4
Ethos Financial Group
Pennsylvania
$8K 23,700 – –
MCM
5
MAI Capital Management
Ohio
$6.4K 20,000 – –
LDB
6
Lee, Danner & Bass
Tennessee
$6K 20,000 – –
AA
7
AlphaMark Advisors
Kentucky
$4K 14,007 – –
KA
8
KLCM Advisors
Wisconsin
$3.2K 10,000 – –
AMG
9
Advisors Management Group
Wisconsin
$3K 10,270 – –
MWM
10
Maripau Wealth Management
Indiana
– – -39,493 Closed
SL
11
Sentinus LLC
Illinois
– – -12,925 Closed
CMP
12
Coston McIsaac & Partners
Maine
$0 1,000 – –
HFS
13
Hantz Financial Services
Michigan
$0 250 – –